📣 #MedSafetyWeek kicks off today!

User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active
 

 

 

 📣 #MedSafetyWeek kicks off today!

📣 #MedSafetyWeek bermula hari ini!

 Hey-Card-2

 

Throughout the week we are encouraging people to use NPRA ADR/AEFI Reporting System to report suspected side effects from medicines. 

Help us monitor the safety of all medicines,
#ReportSideEffects via NPRA (👉 as a healthcare professional or 👉 a consumer) through 🌐 www.npra.gov.my.


 🎧 Tune in to #DrugSafetyMatters  (👉 ow.ly/5F3q50Q3QwL)
for an interview with Mitul Jadeja from the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK to find out:

💊 Why under-reporting plagues all pharmacovigilance systems

💊 What regulators can do to encourage people to report side effects

 💊 Why we need reports from both patients and healthcare professionals

ColdBlob-Pharmacist 

Sepanjang minggu ini, kami ingin menggalakkan orang ramai untuk menggunakan Sistem Pelaporan ADR/AEFI NPRA
untuk melaporkan kesan sampingan yang disyaki disebabkan oleh ubat-ubatan.

Bantu kami memantau keselamatan semua ubat,
#ReportSideEffects melalui NPRA (👉 sebagai anggota kesihatan atau 👉 sebagai pengguna) melalui 🌐 www.npra.gov.my)

 🎧 Mari dengar temubual bersama Mitul Jadeja daripada Medicines & Healthcare products Regulatory Agency (MHRA) di UK
melalui #DrugSafetyMatters (👉 ow.ly/5F3q50Q3QwL) untuk mengetahui:

💊 Mengapa kurangnya pelaporan kesan sampingan menjadi masalah dalam semua sistem farmakovigilans di seluruh dunia

💊 Apa yang boleh dilakukan oleh pihak yang bertanggungjawab untuk menggalakkan orang ramai supaya melaporkan kesan sampingan

💊 Mengapa kita memerlukan laporan daripada pesakit dan anggota kesihatan

 

#PatientSafety #Pharmacovigilance #NPRA #laporkesansampingan #ConSERF

 

 

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Saturday 20 July 2024, 01:25:04.
© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Main Menu English

Industry Menu